カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の大腿動脈カニューレ市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Femoral Arterial Cannulae Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17708）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17708
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：90
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の大腿動脈カニューレ市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

大腿動脈カニューレ市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の大腿動脈カニューレの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

大腿動脈カニューレ市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ユニポーラ大腿動脈カニューレ、バイポーラ大腿動脈カニューレ

用途別セグメントは次のように区分されます。
・従来型心肺バイパス手術、体外膜肺酸素療法（ECMO）、血液透析、その他

世界の大腿動脈カニューレ市場の主要な市場プレーヤーは以下のとおりです。
・Medtronic、Edward Lifescience、LivaNova、Surge Cardiovascular、Kangxin Medical、Charlice Medical、Xenios AG

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、大腿動脈カニューレ製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な大腿動脈カニューレメーカーの企業概要、2019年～2022年までの大腿動脈カニューレの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な大腿動脈カニューレメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別大腿動脈カニューレの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの大腿動脈カニューレの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での大腿動脈カニューレ市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および大腿動脈カニューレの産業チェーンを掲載しています。
・第13、14、15章では、大腿動脈カニューレの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 大腿動脈カニューレの概要
- 種類別分析（2017年vs2021年vs2028年）：ユニポーラ大腿動脈カニューレ、バイポーラ大腿動脈カニューレ
- 用途別分析（2017年vs2021年vs2028年）：従来型心肺バイパス手術、体外膜肺酸素療法（ECMO）、血液透析、その他
- 世界の大腿動脈カニューレ市場規模・予測
- 世界の大腿動脈カニューレ生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Medtronic、Edward Lifescience、LivaNova、Surge Cardiovascular、Kangxin Medical、Charlice Medical、Xenios AG
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ユニポーラ大腿動脈カニューレ、バイポーラ大腿動脈カニューレ
・用途別分析2017年-2028年：従来型心肺バイパス手術、体外膜肺酸素療法（ECMO）、血液透析、その他
・大腿動脈カニューレの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・大腿動脈カニューレのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・大腿動脈カニューレのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・大腿動脈カニューレの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・大腿動脈カニューレの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Femoral Arterial Cannulae market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Femoral Arterial Cannulae market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Traditional cardiopulmonary bypass surgery accounting for % of the Femoral Arterial Cannulae global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Unipolar Femoral Arterial Cannulae segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Femoral Arterial Cannulae include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, and Kangxin Medical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Femoral Arterial Cannulae market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Unipolar Femoral Arterial Cannulae
Bipolar Femoral Arterial Cannulae
Market segment by Application can be divided into
Traditional cardiopulmonary bypass surgery
Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
Hemodialysis
other
The key market players for global Femoral Arterial Cannulae market are listed below:
Medtronic
Edward Lifescience
LivaNova
Surge Cardiovascular
Kangxin Medical
Charlice Medical
Xenios AG
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Femoral Arterial Cannulae product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Femoral Arterial Cannulae, with price, sales, revenue and global market share of Femoral Arterial Cannulae from 2019 to 2022.
Chapter 3, the Femoral Arterial Cannulae competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Femoral Arterial Cannulae breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Femoral Arterial Cannulae market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Femoral Arterial Cannulae.
Chapter 13, 14, and 15, to describe Femoral Arterial Cannulae sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Femoral Arterial Cannulae Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Femoral Arterial Cannulae Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Unipolar Femoral Arterial Cannulae
1.2.3 Bipolar Femoral Arterial Cannulae
1.3 Market Analysis by Application
1.3.1 Overview: Global Femoral Arterial Cannulae Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Traditional cardiopulmonary bypass surgery
1.3.3 Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
1.3.4 Hemodialysis
1.3.5 other
1.4 Global Femoral Arterial Cannulae Market Size & Forecast
1.4.1 Global Femoral Arterial Cannulae Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Femoral Arterial Cannulae Sales in Volume (2017-2028)
1.4.3 Global Femoral Arterial Cannulae Price (2017-2028)
1.5 Global Femoral Arterial Cannulae Production Capacity Analysis
1.5.1 Global Femoral Arterial Cannulae Total Production Capacity (2017-2028)
1.5.2 Global Femoral Arterial Cannulae Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Femoral Arterial Cannulae Market Drivers
1.6.2 Femoral Arterial Cannulae Market Restraints
1.6.3 Femoral Arterial Cannulae Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Femoral Arterial Cannulae Product and Services
2.1.4 Medtronic Femoral Arterial Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Edward Lifescience
2.2.1 Edward Lifescience Details
2.2.2 Edward Lifescience Major Business
2.2.3 Edward Lifescience Femoral Arterial Cannulae Product and Services
2.2.4 Edward Lifescience Femoral Arterial Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 LivaNova
2.3.1 LivaNova Details
2.3.2 LivaNova Major Business
2.3.3 LivaNova Femoral Arterial Cannulae Product and Services
2.3.4 LivaNova Femoral Arterial Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Surge Cardiovascular
2.4.1 Surge Cardiovascular Details
2.4.2 Surge Cardiovascular Major Business
2.4.3 Surge Cardiovascular Femoral Arterial Cannulae Product and Services
2.4.4 Surge Cardiovascular Femoral Arterial Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Kangxin Medical
2.5.1 Kangxin Medical Details
2.5.2 Kangxin Medical Major Business
2.5.3 Kangxin Medical Femoral Arterial Cannulae Product and Services
2.5.4 Kangxin Medical Femoral Arterial Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Charlice Medical
2.6.1 Charlice Medical Details
2.6.2 Charlice Medical Major Business
2.6.3 Charlice Medical Femoral Arterial Cannulae Product and Services
2.6.4 Charlice Medical Femoral Arterial Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Xenios AG
2.7.1 Xenios AG Details
2.7.2 Xenios AG Major Business
2.7.3 Xenios AG Femoral Arterial Cannulae Product and Services
2.7.4 Xenios AG Femoral Arterial Cannulae Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Femoral Arterial Cannulae Breakdown Data by Manufacturer
3.1 Global Femoral Arterial Cannulae Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Femoral Arterial Cannulae Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Femoral Arterial Cannulae
3.4 Market Concentration Rate
3.4.1 Top 3 Femoral Arterial Cannulae Manufacturer Market Share in 2021
3.4.2 Top 6 Femoral Arterial Cannulae Manufacturer Market Share in 2021
3.5 Global Femoral Arterial Cannulae Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Femoral Arterial Cannulae Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Femoral Arterial Cannulae Market Size by Region
4.1.1 Global Femoral Arterial Cannulae Sales in Volume by Region (2017-2028)
4.1.2 Global Femoral Arterial Cannulae Revenue by Region (2017-2028)
4.2 North America Femoral Arterial Cannulae Revenue (2017-2028)
4.3 Europe Femoral Arterial Cannulae Revenue (2017-2028)
4.4 Asia-Pacific Femoral Arterial Cannulae Revenue (2017-2028)
4.5 South America Femoral Arterial Cannulae Revenue (2017-2028)
4.6 Middle East and Africa Femoral Arterial Cannulae Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Femoral Arterial Cannulae Sales in Volume by Type (2017-2028)
5.2 Global Femoral Arterial Cannulae Revenue by Type (2017-2028)
5.3 Global Femoral Arterial Cannulae Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Femoral Arterial Cannulae Sales in Volume by Application (2017-2028)
6.2 Global Femoral Arterial Cannulae Revenue by Application (2017-2028)
6.3 Global Femoral Arterial Cannulae Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Femoral Arterial Cannulae Sales by Type (2017-2028)
7.2 North America Femoral Arterial Cannulae Sales by Application (2017-2028)
7.3 North America Femoral Arterial Cannulae Market Size by Country
7.3.1 North America Femoral Arterial Cannulae Sales in Volume by Country (2017-2028)
7.3.2 North America Femoral Arterial Cannulae Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Femoral Arterial Cannulae Sales by Type (2017-2028)
8.2 Europe Femoral Arterial Cannulae Sales by Application (2017-2028)
8.3 Europe Femoral Arterial Cannulae Market Size by Country
8.3.1 Europe Femoral Arterial Cannulae Sales in Volume by Country (2017-2028)
8.3.2 Europe Femoral Arterial Cannulae Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Femoral Arterial Cannulae Sales by Type (2017-2028)
9.2 Asia-Pacific Femoral Arterial Cannulae Sales by Application (2017-2028)
9.3 Asia-Pacific Femoral Arterial Cannulae Market Size by Region
9.3.1 Asia-Pacific Femoral Arterial Cannulae Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Femoral Arterial Cannulae Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Femoral Arterial Cannulae Sales by Type (2017-2028)
10.2 South America Femoral Arterial Cannulae Sales by Application (2017-2028)
10.3 South America Femoral Arterial Cannulae Market Size by Country
10.3.1 South America Femoral Arterial Cannulae Sales in Volume by Country (2017-2028)
10.3.2 South America Femoral Arterial Cannulae Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Femoral Arterial Cannulae Sales by Type (2017-2028)
11.2 Middle East & Africa Femoral Arterial Cannulae Sales by Application (2017-2028)
11.3 Middle East & Africa Femoral Arterial Cannulae Market Size by Country
11.3.1 Middle East & Africa Femoral Arterial Cannulae Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Femoral Arterial Cannulae Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Femoral Arterial Cannulae and Key Manufacturers
12.2 Manufacturing Costs Percentage of Femoral Arterial Cannulae
12.3 Femoral Arterial Cannulae Production Process
12.4 Femoral Arterial Cannulae Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Femoral Arterial Cannulae Typical Distributors
13.3 Femoral Arterial Cannulae Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Femoral Arterial Cannulae Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Femoral Arterial Cannulae Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Medtronic Basic Information, Manufacturing Base and Competitors
Table 4. Medtronic Major Business
Table 5. Medtronic Femoral Arterial Cannulae Product and Services
Table 6. Medtronic Femoral Arterial Cannulae Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Edward Lifescience Basic Information, Manufacturing Base and Competitors
Table 8. Edward Lifescience Major Business
Table 9. Edward Lifescience Femoral Arterial Cannulae Product and Services
Table 10. Edward Lifescience Femoral Arterial Cannulae Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. LivaNova Basic Information, Manufacturing Base and Competitors
Table 12. LivaNova Major Business
Table 13. LivaNova Femoral Arterial Cannulae Product and Services
Table 14. LivaNova Femoral Arterial Cannulae Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Surge Cardiovascular Basic Information, Manufacturing Base and Competitors
Table 16. Surge Cardiovascular Major Business
Table 17. Surge Cardiovascular Femoral Arterial Cannulae Product and Services
Table 18. Surge Cardiovascular Femoral Arterial Cannulae Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Kangxin Medical Basic Information, Manufacturing Base and Competitors
Table 20. Kangxin Medical Major Business
Table 21. Kangxin Medical Femoral Arterial Cannulae Product and Services
Table 22. Kangxin Medical Femoral Arterial Cannulae Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Charlice Medical Basic Information, Manufacturing Base and Competitors
Table 24. Charlice Medical Major Business
Table 25. Charlice Medical Femoral Arterial Cannulae Product and Services
Table 26. Charlice Medical Femoral Arterial Cannulae Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Xenios AG Basic Information, Manufacturing Base and Competitors
Table 28. Xenios AG Major Business
Table 29. Xenios AG Femoral Arterial Cannulae Product and Services
Table 30. Xenios AG Femoral Arterial Cannulae Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Global Femoral Arterial Cannulae Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 32. Global Femoral Arterial Cannulae Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 33. Market Position of Manufacturers in Femoral Arterial Cannulae, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 34. Global Femoral Arterial Cannulae Production Capacity by Company, (K Units): 2020 VS 2021
Table 35. Head Office and Femoral Arterial Cannulae Production Site of Key Manufacturer
Table 36. Femoral Arterial Cannulae New Entrant and Capacity Expansion Plans
Table 37. Femoral Arterial Cannulae Mergers & Acquisitions in the Past Five Years
Table 38. Global Femoral Arterial Cannulae Sales by Region (2017-2022) & (K Units)
Table 39. Global Femoral Arterial Cannulae Sales by Region (2023-2028) & (K Units)
Table 40. Global Femoral Arterial Cannulae Revenue by Region (2017-2022) & (USD Million)
Table 41. Global Femoral Arterial Cannulae Revenue by Region (2023-2028) & (USD Million)
Table 42. Global Femoral Arterial Cannulae Sales by Type (2017-2022) & (K Units)
Table 43. Global Femoral Arterial Cannulae Sales by Type (2023-2028) & (K Units)
Table 44. Global Femoral Arterial Cannulae Revenue by Type (2017-2022) & (USD Million)
Table 45. Global Femoral Arterial Cannulae Revenue by Type (2023-2028) & (USD Million)
Table 46. Global Femoral Arterial Cannulae Price by Type (2017-2022) & (US$/Unit)
Table 47. Global Femoral Arterial Cannulae Price by Type (2023-2028) & (US$/Unit)
Table 48. Global Femoral Arterial Cannulae Sales by Application (2017-2022) & (K Units)
Table 49. Global Femoral Arterial Cannulae Sales by Application (2023-2028) & (K Units)
Table 50. Global Femoral Arterial Cannulae Revenue by Application (2017-2022) & (USD Million)
Table 51. Global Femoral Arterial Cannulae Revenue by Application (2023-2028) & (USD Million)
Table 52. Global Femoral Arterial Cannulae Price by Application (2017-2022) & (US$/Unit)
Table 53. Global Femoral Arterial Cannulae Price by Application (2023-2028) & (US$/Unit)
Table 54. North America Femoral Arterial Cannulae Sales by Country (2017-2022) & (K Units)
Table 55. North America Femoral Arterial Cannulae Sales by Country (2023-2028) & (K Units)
Table 56. North America Femoral Arterial Cannulae Revenue by Country (2017-2022) & (USD Million)
Table 57. North America Femoral Arterial Cannulae Revenue by Country (2023-2028) & (USD Million)
Table 58. North America Femoral Arterial Cannulae Sales by Type (2017-2022) & (K Units)
Table 59. North America Femoral Arterial Cannulae Sales by Type (2023-2028) & (K Units)
Table 60. North America Femoral Arterial Cannulae Sales by Application (2017-2022) & (K Units)
Table 61. North America Femoral Arterial Cannulae Sales by Application (2023-2028) & (K Units)
Table 62. Europe Femoral Arterial Cannulae Sales by Country (2017-2022) & (K Units)
Table 63. Europe Femoral Arterial Cannulae Sales by Country (2023-2028) & (K Units)
Table 64. Europe Femoral Arterial Cannulae Revenue by Country (2017-2022) & (USD Million)
Table 65. Europe Femoral Arterial Cannulae Revenue by Country (2023-2028) & (USD Million)
Table 66. Europe Femoral Arterial Cannulae Sales by Type (2017-2022) & (K Units)
Table 67. Europe Femoral Arterial Cannulae Sales by Type (2023-2028) & (K Units)
Table 68. Europe Femoral Arterial Cannulae Sales by Application (2017-2022) & (K Units)
Table 69. Europe Femoral Arterial Cannulae Sales by Application (2023-2028) & (K Units)
Table 70. Asia-Pacific Femoral Arterial Cannulae Sales by Region (2017-2022) & (K Units)
Table 71. Asia-Pacific Femoral Arterial Cannulae Sales by Region (2023-2028) & (K Units)
Table 72. Asia-Pacific Femoral Arterial Cannulae Revenue by Region (2017-2022) & (USD Million)
Table 73. Asia-Pacific Femoral Arterial Cannulae Revenue by Region (2023-2028) & (USD Million)
Table 74. Asia-Pacific Femoral Arterial Cannulae Sales by Type (2017-2022) & (K Units)
Table 75. Asia-Pacific Femoral Arterial Cannulae Sales by Type (2023-2028) & (K Units)
Table 76. Asia-Pacific Femoral Arterial Cannulae Sales by Application (2017-2022) & (K Units)
Table 77. Asia-Pacific Femoral Arterial Cannulae Sales by Application (2023-2028) & (K Units)
Table 78. South America Femoral Arterial Cannulae Sales by Country (2017-2022) & (K Units)
Table 79. South America Femoral Arterial Cannulae Sales by Country (2023-2028) & (K Units)
Table 80. South America Femoral Arterial Cannulae Revenue by Country (2017-2022) & (USD Million)
Table 81. South America Femoral Arterial Cannulae Revenue by Country (2023-2028) & (USD Million)
Table 82. South America Femoral Arterial Cannulae Sales by Type (2017-2022) & (K Units)
Table 83. South America Femoral Arterial Cannulae Sales by Type (2023-2028) & (K Units)
Table 84. South America Femoral Arterial Cannulae Sales by Application (2017-2022) & (K Units)
Table 85. South America Femoral Arterial Cannulae Sales by Application (2023-2028) & (K Units)
Table 86. Middle East & Africa Femoral Arterial Cannulae Sales by Region (2017-2022) & (K Units)
Table 87. Middle East & Africa Femoral Arterial Cannulae Sales by Region (2023-2028) & (K Units)
Table 88. Middle East & Africa Femoral Arterial Cannulae Revenue by Region (2017-2022) & (USD Million)
Table 89. Middle East & Africa Femoral Arterial Cannulae Revenue by Region (2023-2028) & (USD Million)
Table 90. Middle East & Africa Femoral Arterial Cannulae Sales by Type (2017-2022) & (K Units)
Table 91. Middle East & Africa Femoral Arterial Cannulae Sales by Type (2023-2028) & (K Units)
Table 92. Middle East & Africa Femoral Arterial Cannulae Sales by Application (2017-2022) & (K Units)
Table 93. Middle East & Africa Femoral Arterial Cannulae Sales by Application (2023-2028) & (K Units)
Table 94. Femoral Arterial Cannulae Raw Material
Table 95. Key Manufacturers of Femoral Arterial Cannulae Raw Materials
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Femoral Arterial Cannulae Typical Distributors
Table 99. Femoral Arterial Cannulae Typical Customers
List of Figures
Figure 1. Femoral Arterial Cannulae Picture
Figure 2. Global Femoral Arterial Cannulae Revenue Market Share by Type in 2021
Figure 3. Unipolar Femoral Arterial Cannulae
Figure 4. Bipolar Femoral Arterial Cannulae
Figure 5. Global Femoral Arterial Cannulae Revenue Market Share by Application in 2021
Figure 6. Traditional cardiopulmonary bypass surgery
Figure 7. Extracorporeal Membrane Pulmonary Oxygenation (ECMO)
Figure 8. Hemodialysis
Figure 9. other
Figure 10. Global Femoral Arterial Cannulae Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Femoral Arterial Cannulae Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Femoral Arterial Cannulae Sales (2017-2028) & (K Units)
Figure 13. Global Femoral Arterial Cannulae Price (2017-2028) & (US$/Unit)
Figure 14. Global Femoral Arterial Cannulae Production Capacity (2017-2028) & (K Units)
Figure 15. Global Femoral Arterial Cannulae Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Femoral Arterial Cannulae Market Drivers
Figure 17. Femoral Arterial Cannulae Market Restraints
Figure 18. Femoral Arterial Cannulae Market Trends
Figure 19. Global Femoral Arterial Cannulae Sales Market Share by Manufacturer in 2021
Figure 20. Global Femoral Arterial Cannulae Revenue Market Share by Manufacturer in 2021
Figure 21. Femoral Arterial Cannulae Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Femoral Arterial Cannulae Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Femoral Arterial Cannulae Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Femoral Arterial Cannulae Sales Market Share by Region (2017-2028)
Figure 25. Global Femoral Arterial Cannulae Revenue Market Share by Region (2017-2028)
Figure 26. North America Femoral Arterial Cannulae Revenue (2017-2028) & (USD Million)
Figure 27. Europe Femoral Arterial Cannulae Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Femoral Arterial Cannulae Revenue (2017-2028) & (USD Million)
Figure 29. South America Femoral Arterial Cannulae Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Femoral Arterial Cannulae Revenue (2017-2028) & (USD Million)
Figure 31. Global Femoral Arterial Cannulae Sales Market Share by Type (2017-2028)
Figure 32. Global Femoral Arterial Cannulae Revenue Market Share by Type (2017-2028)
Figure 33. Global Femoral Arterial Cannulae Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Femoral Arterial Cannulae Sales Market Share by Application (2017-2028)
Figure 35. Global Femoral Arterial Cannulae Revenue Market Share by Application (2017-2028)
Figure 36. Global Femoral Arterial Cannulae Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Femoral Arterial Cannulae Sales Market Share by Type (2017-2028)
Figure 38. North America Femoral Arterial Cannulae Sales Market Share by Application (2017-2028)
Figure 39. North America Femoral Arterial Cannulae Sales Market Share by Country (2017-2028)
Figure 40. North America Femoral Arterial Cannulae Revenue Market Share by Country (2017-2028)
Figure 41. United States Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Femoral Arterial Cannulae Sales Market Share by Type (2017-2028)
Figure 45. Europe Femoral Arterial Cannulae Sales Market Share by Application (2017-2028)
Figure 46. Europe Femoral Arterial Cannulae Sales Market Share by Country (2017-2028)
Figure 47. Europe Femoral Arterial Cannulae Revenue Market Share by Country (2017-2028)
Figure 48. Germany Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Femoral Arterial Cannulae Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Femoral Arterial Cannulae Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Femoral Arterial Cannulae Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Femoral Arterial Cannulae Revenue Market Share by Region (2017-2028)
Figure 57. China Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Femoral Arterial Cannulae Sales Market Share by Type (2017-2028)
Figure 64. South America Femoral Arterial Cannulae Sales Market Share by Application (2017-2028)
Figure 65. South America Femoral Arterial Cannulae Sales Market Share by Country (2017-2028)
Figure 66. South America Femoral Arterial Cannulae Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Femoral Arterial Cannulae Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Femoral Arterial Cannulae Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Femoral Arterial Cannulae Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Femoral Arterial Cannulae Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Femoral Arterial Cannulae Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Femoral Arterial Cannulae in 2021
Figure 78. Manufacturing Process Analysis of Femoral Arterial Cannulae
Figure 79. Femoral Arterial Cannulae Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の大腿静脈カニューレ市場2022年：市場規模予測（～2028年）
  • 世界の大腿静脈カテーテル市場2022年：市場規模予測（～2028年）
  • 世界の手術用カニューレ市場2022年：市場規模予測（～2028年）
  • 世界の手術用シリコンカニューレ市場2022年：市場規模予測（～2028年）
  • 世界の金属製外科用カニューレ市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17708 )"世界の大腿動脈カニューレ市場2022年：市場規模予測（～2028年）" (英文：Global Femoral Arterial Cannulae Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。